Sign inJoin waitlistJoin the waitlist

Awewura Kwara

VA Section Chief · University of Florida College of Medicine

Credentials: · · · ·

History

University of Florida College of Medicine
Present
University of Florida College of Medicine
Present

Infectious Disease
Tulane University
2001–2003
Internal Medicine
Tulane University School of Medicine
1998–2001
John H. Stroger Jr. Hospital of Cook County
1994–1997
Tulane University
UNIV OF GHANA, ACCRA
1988–1992
University of Ghana

Research

CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients
AIDS · 2009 · First of 5 authors · Corresponding · 102 citations
CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
British Journal of Clinical Pharmacology · 2009 · First of 5 authors · Corresponding · 99 citations
Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy
Clinical Infectious Diseases · 2008 · First of 12 authors · Corresponding · 70 citations

CP
Charles Peloquin
24 papers
OO
Oluwayemisi Ojewale
11 papers · 1 as a resident
TF
Timothy Flanigan
9 papers
DG
David Greenblatt
7 papers
Jane Carter
5 papers
Michael Lauzardo
5 papers
Robert Cook
5 papers
Larry Brown
4 papers
Kate Guthrie
3 papers
Kenneth Sherman
3 papers
Aadia Rana
2 papers
BD
Bouke Dejong
2 papers

Grants

Addressing Research Gaps to Optimize Dolutegravir-Based ART in Children and Adolescents
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · University of Florida
2024–2029
Pharmacokinetics of Anti-Tuberculosis and Antiretroviral Drugs in Children
National Institute of Child Health and Human Development · R01
Contact PI · $6M · University of Florida
2012–2025
Pharmacokinetics and Pharmacodynamics of Dolutegravir in Children Weighing ≥20 Kg Living with HIV with and Without TB Coinfection
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $385.2K · University of Florida
2020–2024
Adherence and Intracellular Pharmacology of Tenofovir and HBV Suppression in People with HBV/HIV Coinfection
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $432.1K · University of Florida
2020–2024

Clinical trials

Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection
Principal investigator · Completed
University of Florida
2019–2025
Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
Principal investigator · Completed
University of Florida
2019–2024
Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet
Principal investigator · Completed
University of Florida
2019–2024
Rifampin and Efavirenz Interactions in Older Children
Principal investigator · Unknown
The Miriam Hospital
2012–2017